IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.3929
-0.0062 (-1.55%)
At close: Oct 13, 2025, 4:00 PM EDT
0.3950
+0.0021 (0.53%)
After-hours: Oct 13, 2025, 5:59 PM EDT
IGC Pharma Stock Forecast
Stock Price Forecast
The 2 analysts that cover IGC Pharma stock have a consensus rating of "Strong Buy" and an average price target of $4.00, which forecasts a 918.07% increase in the stock price over the next year. The lowest target is $3.50 and the highest is $4.50.
Price Target: $4.00 (+918.07%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 26, 2025.
Analyst Ratings
The average analyst rating for IGC Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $4.25 → $4.5 | Strong Buy | Maintains | $4.25 → $4.5 | +1,045.33% | Aug 26, 2025 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Reiterates $3.5 | Strong Buy | Reiterates | $3.5 | +790.81% | Mar 6, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $4 → $4.25 | Strong Buy | Maintains | $4 → $4.25 | +981.70% | Feb 24, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.75 → $4 | Strong Buy | Maintains | $3.75 → $4 | +918.07% | Dec 5, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.5 → $3.75 | Strong Buy | Maintains | $3.5 → $3.75 | +854.44% | Sep 3, 2024 |
Financial Forecast
Revenue This Year
1.32M
from 1.27M
Increased by 3.54%
Revenue Next Year
1.52M
from 1.32M
Increased by 15.12%
EPS This Year
-0.06
from -0.09
EPS Next Year
-0.07
from -0.06
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 1.4M | 1.6M |
| Avg | 1.3M | 1.5M |
| Low | 1.3M | 1.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 7.6% | 19.7% |
| Avg | 3.5% | 15.1% |
| Low | 0.5% | 11.7% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -0.06 | -0.07 |
| Avg | -0.06 | -0.07 |
| Low | -0.06 | -0.06 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.